{"id":71065,"date":"2024-11-07T18:00:00","date_gmt":"2024-11-07T17:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/"},"modified":"2024-11-07T18:00:00","modified_gmt":"2024-11-07T17:00:00","slug":"ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/","title":{"rendered":"Ipsen &#8211; Octobre 2024 &#8211; Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social"},"content":{"rendered":"<p align=\"center\"><strong>Information mensuelle relative au nombre total des droits de vote<\/strong><br \/><strong>et d\u2019actions composant le capital social<\/strong><\/p>\n<p align=\"center\">(conform\u00e9ment \u00e0 l\u2019article L.233-8 II du Code de commerce<br \/>et \u00e0 l\u2019article 223-16 du R\u00e8glement G\u00e9n\u00e9ral de l\u2019Autorit\u00e9 des March\u00e9s Financiers)<\/p>\n<p align=\"left\">Place de cotation\u00a0: Euronext Paris <br \/>Code ISIN\u00a0: FR 0010259150<br \/>LEI : 549300M6SGDPB4Z94P11<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"width:27.2%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle\"><strong>Date <\/strong><\/td>\n<td style=\"width:25.08%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\"><strong>Nombre total d\u2019actions composant le capital social<\/strong><\/td>\n<td style=\"width:47.72%;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\"><strong>Nombre total de droits de vote <sup>(1)<\/sup><\/strong><\/td>\n<\/tr>\n<tr>\n<td rowspan=\"2\" style=\"width:27.2%;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: center;vertical-align: middle\">31 octobre 2024<\/td>\n<td rowspan=\"2\" style=\"width:25.08%;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\">83\u00a0814 526<\/td>\n<td style=\"width:47.72%;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\">Total brut* des droits de vote\u00a0: 132\u00a0135 791<\/td>\n<\/tr>\n<tr>\n<td style=\"width:47.72%;border-right: solid black 1pt;border-bottom: solid black 1pt;text-align: center;vertical-align: middle\">Total net** des droits de vote : 131\u00a0036 178<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\"><sup>(1)<\/sup> Pr\u00e9sence d\u2019une clause statutaire imposant une obligation de d\u00e9claration de franchissement de seuil compl\u00e9mentaire de celle relative aux seuils l\u00e9gaux (article 10).<\/p>\n<p align=\"justify\">* Total brut = nombre total de droits de vote attach\u00e9s au nombre total d\u2019actions, dont le nombre d\u2019actions b\u00e9n\u00e9ficiant du droit de vote double et le nombre d\u2019actions autod\u00e9tenues. Le \u00ab\u00a0Total brut\u00a0\u00bb sert de base de calcul pour les franchissements de seuils.<\/p>\n<p align=\"justify\">** Total net = nombre total de droits de vote attach\u00e9s au nombre total d\u2019actions \u2013 actions priv\u00e9es de droits de vote.<\/p>\n<p>\u00a0<\/p>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Pi\u00e8ce jointe<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=i85lEop_giQVCY24-uW16V81L8PsxiCUw5S10EI8KxRj_VOYY2wgErZcX-bggGYU5TvWL6qKwW9S-KWvxphHq9ENY48J0zGYUifaOgmD4KiNOom-71ukKdHCDmeKQnGY7672_jnjB7Zls5MQD7TlCNDGD50yD5RwTMlh7v0DOBee9ZjznNH13Ts1T1JvPoEBnTvl4iHbCf-QQjLQNDXBqp7xiLYDr-iYXLS04Qtp7-AnHvEFzjzb3Lbn9yqINxU38W0J6bZLqS3msaYz_iPq_w==\" title=\"D&#233;claration relative au nombre total des droits de vote et d\u2019actions - Octobre 2024\" rel=\"nofollow noopener\">D&#233;claration relative au nombre total des droits de vote et d\u2019actions &#8211; Octobre 2024<\/a>\n      <\/li>\n<\/ul>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[6364],"tags":[],"class_list":["post-71065","press_release","type-press_release","status-publish","hentry","category-regulated-info-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Ipsen &#8211; Octobre 2024 &#8211; Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social\",\"datePublished\":\"2024-11-07T17:00:00+00:00\",\"dateModified\":\"2024-11-07T17:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\"},\"wordCount\":220,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"articleSection\":[\"Informations r\u00e9glement\u00e9es\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\",\"name\":\"Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"datePublished\":\"2024-11-07T17:00:00+00:00\",\"dateModified\":\"2024-11-07T17:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen &#8211; Octobre 2024 &#8211; Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social","og_url":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/","og_site_name":"Global","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Ipsen &#8211; Octobre 2024 &#8211; Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social","datePublished":"2024-11-07T17:00:00+00:00","dateModified":"2024-11-07T17:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/"},"wordCount":220,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","articleSection":["Informations r\u00e9glement\u00e9es"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/","url":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/","name":"Ipsen - Octobre 2024 - Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","datePublished":"2024-11-07T17:00:00+00:00","dateModified":"2024-11-07T17:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MzY5N2U5NDEtZjE3OC00M2NmLWE2MDktNzUwOWQ3ODczNWMzLTEyNjgxMTY=\/tiny\/Ipsen-Pharma.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-octobre-2024-information-mensuelle-relative-au-nombre-total-des-droits-de-vote-et-dactions-composant-le-capital-social-2976967\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen &#8211; Octobre 2024 &#8211; Information mensuelle relative au nombre total des droits de vote et d\u2019actions composant le capital social"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/71065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/71065\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=71065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=71065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=71065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}